Marina Gottikh

Title: Marina Gottikh: Innovator in Antisense Oligonucleotide Technology

Introduction

Marina Gottikh is a prominent inventor based in Moscow, Russia. She has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotides that can modify or inhibit gene expression. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Marina Gottikh holds a patent for "Oligonucleotides containing an antisense sequence stabilized by a secondary structure, pharmaceutical compositions containing them and method of blocking gene expression using them." This patent describes oligonucleotides capable of modifying or inhibiting in vivo or in vitro expression of a target gene. The oligonucleotide features an antisense sequence, at least one secondary structure, and optionally a supplementary nucleotide sequence located at one and/or both ends of the antisense sequence. The secondary structure disintegrates upon attachment of the oligonucleotide to a target nucleic acid. This invention also includes a pharmaceutical composition containing such an oligonucleotide as an active ingredient and a method of treatment using it.

Career Highlights

Throughout her career, Marina has worked with notable organizations, including Bioalliance Pharma and the Centre National De La Recherche Scientifique. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Marina Gottikh has collaborated with Calude Malvy, enhancing her research and expanding the impact of her work in the scientific community.

Conclusion

Marina Gottikh's contributions to the field of biotechnology, particularly through her patented innovations, highlight her role as a key figure in advancing gene expression technologies. Her work continues to influence the development of new therapeutic strategies.